There is evidence that β-catenin overexpression and its increased or constitutive activation drives leukemia initiation in some types of myeloid malignancies [89,100,101], which is associated with poor prognosis [102,103,104] and can be associated to Wnt3a or Wnt5a activity [105]. The gene discussed is WNT5A; the disease is leukemia.